Healthcare

Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States

EPYSQLI® (eculizumab-aagh) is now available to patients living with difficult-to-treat rare diseases like paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome...

Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease

ATTENTION-AD trial data through 192 weeks presented at AD/PDTM 2025 Conference Prespecified delayed-start analysis indicate disease-modifying effect of oral blarcamesine...

BlackDoctor.org Announces Inductees in First Hall of Fame, BDOs Highest Distinction, Recognizing Lifetime Achievements in the US Healthcare Industry

CHICAGO, April 4, 2025 /PRNewswire/ -- In a historic moment, BlackDoctor.org (BDO) inducts its first class into the inaugural TBH...

TALON selects Litchfield Underwriters to provide Comprehensive Stop-Loss Coverage for Transformative Equitable Healthcare Pricing Network

PORTSMOUTH, N.H., April 4, 2025 /PRNewswire/ -- Litchfield Underwriters, industry leaders in providing superior self-funded reinsurance solutions to commercial clients,...

error: Content is protected !!